Global Hormonal Drugs Market Growth 2022-2028
Hormone drugs are drugs that use human or animal hormones (including organic substances with the same structure and action principle as hormones) as active ingredients.
The global market for Hormonal Drugs is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Hormonal Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Hormonal Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Hormonal Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Hormonal Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Hormonal Drugs players cover Merck, Roche, Novartis, Mitsubishi Tanabe Pharma Korea and Anhui Renhe Pharmaceutical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Hormonal Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Hormonal Drugs market, with both quantitative and qualitative data, to help readers understand how the Hormonal Drugs market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Hormonal Drugs market and forecasts the market size by Type (Intravenous Injection, Take Orally and Topical), by Sales Channels (Hospital, Pharmacy and Clinic,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Intravenous Injection
Take Orally
Topical
Others
Segmentation by sales channels
Hospital
Pharmacy
Clinic
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Merck
Roche
Novartis
Mitsubishi Tanabe Pharma Korea
Anhui Renhe Pharmaceutical
Shanghai ZhongHua Pharmaceutical Nantong
He'nan Xuchang Huaren Pharmaceutical
Wuhan Wujing Pharmaceutical
Harbin Pharmaceutical Group
Changzhou Siyao Pharmaceuticals
Hunan Wzt Pharmaceutical
Tianjin Tianyao Pharmaceutical
Henan Lihua Pharmaceutical
Hubei Tiansheng Pharmaceutica
Shandong Xinhua Pharmaceutical
Huazhong Pharmaceutical
China Resources Zizhu Pharmaceutical
Shanghai CP GENERAL Pharmaceutical
Jiangsu Lianhuan Pharmaceutical
Chapter Introduction
Chapter 1: Scope of Hormonal Drugs, Research Methodology, etc.
Chapter 2: Executive Summary, global Hormonal Drugs market size (sales and revenue) and CAGR, Hormonal Drugs market size by region, by type, by sales channels, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Hormonal Drugs sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Hormonal Drugs sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Hormonal Drugs market size forecast by region, by country, by type, and sales channels.
Chapter 13: Comprehensive company profiles of the leading players, including Merck, Roche, Novartis, Mitsubishi Tanabe Pharma Korea, Anhui Renhe Pharmaceutical, Shanghai ZhongHua Pharmaceutical Nantong, He'nan Xuchang Huaren Pharmaceutical, Wuhan Wujing Pharmaceutical and Harbin Pharmaceutical Group, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Hormonal Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Hormonal Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Hormonal Drugs by Country/Region, 2017, 2022 & 2028
2.2 Hormonal Drugs Segment by Type
2.2.1 Intravenous Injection
2.2.2 Take Orally
2.2.3 Topical
2.2.4 Others
2.3 Hormonal Drugs Sales by Type
2.3.1 Global Hormonal Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Hormonal Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Hormonal Drugs Sale Price by Type (2017-2022)
2.4 Hormonal Drugs Segment by Sales Channels
2.4.1 Hospital
2.4.2 Pharmacy
2.4.3 Clinic
2.5 Hormonal Drugs Sales by Sales Channels
2.5.1 Global Hormonal Drugs Sale Market Share by Sales Channels (2017-2022)
2.5.2 Global Hormonal Drugs Revenue and Market Share by Sales Channels (2017-2022)
2.5.3 Global Hormonal Drugs Sale Price by Sales Channels (2017-2022)
3 Global Hormonal Drugs by Company
3.1 Global Hormonal Drugs Breakdown Data by Company
3.1.1 Global Hormonal Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Hormonal Drugs Sales Market Share by Company (2020-2022)
3.2 Global Hormonal Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Hormonal Drugs Revenue by Company (2020-2022)
3.2.2 Global Hormonal Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Hormonal Drugs Sale Price by Company
3.4 Key Manufacturers Hormonal Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hormonal Drugs Product Location Distribution
3.4.2 Players Hormonal Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Hormonal Drugs by Geographic Region
4.1 World Historic Hormonal Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Hormonal Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Hormonal Drugs Annual Revenue by Geographic Region
4.2 World Historic Hormonal Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Hormonal Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Hormonal Drugs Annual Revenue by Country/Region
4.3 Americas Hormonal Drugs Sales Growth
4.4 APAC Hormonal Drugs Sales Growth
4.5 Europe Hormonal Drugs Sales Growth
4.6 Middle East & Africa Hormonal Drugs Sales Growth
5 Americas
5.1 Americas Hormonal Drugs Sales by Country
5.1.1 Americas Hormonal Drugs Sales by Country (2017-2022)
5.1.2 Americas Hormonal Drugs Revenue by Country (2017-2022)
5.2 Americas Hormonal Drugs Sales by Type
5.3 Americas Hormonal Drugs Sales by Sales Channels
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hormonal Drugs Sales by Region
6.1.1 APAC Hormonal Drugs Sales by Region (2017-2022)
6.1.2 APAC Hormonal Drugs Revenue by Region (2017-2022)
6.2 APAC Hormonal Drugs Sales by Type
6.3 APAC Hormonal Drugs Sales by Sales Channels
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Hormonal Drugs by Country
7.1.1 Europe Hormonal Drugs Sales by Country (2017-2022)
7.1.2 Europe Hormonal Drugs Revenue by Country (2017-2022)
7.2 Europe Hormonal Drugs Sales by Type
7.3 Europe Hormonal Drugs Sales by Sales Channels
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Hormonal Drugs by Country
8.1.1 Middle East & Africa Hormonal Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Hormonal Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Hormonal Drugs Sales by Type
8.3 Middle East & Africa Hormonal Drugs Sales by Sales Channels
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hormonal Drugs
10.3 Manufacturing Process Analysis of Hormonal Drugs
10.4 Industry Chain Structure of Hormonal Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hormonal Drugs Distributors
11.3 Hormonal Drugs Customer
12 World Forecast Review for Hormonal Drugs by Geographic Region
12.1 Global Hormonal Drugs Market Size Forecast by Region
12.1.1 Global Hormonal Drugs Forecast by Region (2023-2028)
12.1.2 Global Hormonal Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Hormonal Drugs Forecast by Type
12.7 Global Hormonal Drugs Forecast by Sales Channels
13 Key Players Analysis
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Hormonal Drugs Product Offered
13.1.3 Merck Hormonal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Roche
13.2.1 Roche Company Information
13.2.2 Roche Hormonal Drugs Product Offered
13.2.3 Roche Hormonal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Roche Main Business Overview
13.2.5 Roche Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis Hormonal Drugs Product Offered
13.3.3 Novartis Hormonal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 Mitsubishi Tanabe Pharma Korea
13.4.1 Mitsubishi Tanabe Pharma Korea Company Information
13.4.2 Mitsubishi Tanabe Pharma Korea Hormonal Drugs Product Offered
13.4.3 Mitsubishi Tanabe Pharma Korea Hormonal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Mitsubishi Tanabe Pharma Korea Main Business Overview
13.4.5 Mitsubishi Tanabe Pharma Korea Latest Developments
13.5 Anhui Renhe Pharmaceutical
13.5.1 Anhui Renhe Pharmaceutical Company Information
13.5.2 Anhui Renhe Pharmaceutical Hormonal Drugs Product Offered
13.5.3 Anhui Renhe Pharmaceutical Hormonal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Anhui Renhe Pharmaceutical Main Business Overview
13.5.5 Anhui Renhe Pharmaceutical Latest Developments
13.6 Shanghai ZhongHua Pharmaceutical Nantong
13.6.1 Shanghai ZhongHua Pharmaceutical Nantong Company Information
13.6.2 Shanghai ZhongHua Pharmaceutical Nantong Hormonal Drugs Product Offered
13.6.3 Shanghai ZhongHua Pharmaceutical Nantong Hormonal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Shanghai ZhongHua Pharmaceutical Nantong Main Business Overview
13.6.5 Shanghai ZhongHua Pharmaceutical Nantong Latest Developments
13.7 He'nan Xuchang Huaren Pharmaceutical
13.7.1 He'nan Xuchang Huaren Pharmaceutical Company Information
13.7.2 He'nan Xuchang Huaren Pharmaceutical Hormonal Drugs Product Offered
13.7.3 He'nan Xuchang Huaren Pharmaceutical Hormonal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 He'nan Xuchang Huaren Pharmaceutical Main Business Overview
13.7.5 He'nan Xuchang Huaren Pharmaceutical Latest Developments
13.8 Wuhan Wujing Pharmaceutical
13.8.1 Wuhan Wujing Pharmaceutical Company Information
13.8.2 Wuhan Wujing Pharmaceutical Hormonal Drugs Product Offered
13.8.3 Wuhan Wujing Pharmaceutical Hormonal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Wuhan Wujing Pharmaceutical Main Business Overview
13.8.5 Wuhan Wujing Pharmaceutical Latest Developments
13.9 Harbin Pharmaceutical Group
13.9.1 Harbin Pharmaceutical Group Company Information
13.9.2 Harbin Pharmaceutical Group Hormonal Drugs Product Offered
13.9.3 Harbin Pharmaceutical Group Hormonal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Harbin Pharmaceutical Group Main Business Overview
13.9.5 Harbin Pharmaceutical Group Latest Developments
13.10 Changzhou Siyao Pharmaceuticals
13.10.1 Changzhou Siyao Pharmaceuticals Company Information
13.10.2 Changzhou Siyao Pharmaceuticals Hormonal Drugs Product Offered
13.10.3 Changzhou Siyao Pharmaceuticals Hormonal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Changzhou Siyao Pharmaceuticals Main Business Overview
13.10.5 Changzhou Siyao Pharmaceuticals Latest Developments
13.11 Hunan Wzt Pharmaceutical
13.11.1 Hunan Wzt Pharmaceutical Company Information
13.11.2 Hunan Wzt Pharmaceutical Hormonal Drugs Product Offered
13.11.3 Hunan Wzt Pharmaceutical Hormonal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Hunan Wzt Pharmaceutical Main Business Overview
13.11.5 Hunan Wzt Pharmaceutical Latest Developments
13.12 Tianjin Tianyao Pharmaceutical
13.12.1 Tianjin Tianyao Pharmaceutical Company Information
13.12.2 Tianjin Tianyao Pharmaceutical Hormonal Drugs Product Offered
13.12.3 Tianjin Tianyao Pharmaceutical Hormonal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Tianjin Tianyao Pharmaceutical Main Business Overview
13.12.5 Tianjin Tianyao Pharmaceutical Latest Developments
13.13 Henan Lihua Pharmaceutical
13.13.1 Henan Lihua Pharmaceutical Company Information
13.13.2 Henan Lihua Pharmaceutical Hormonal Drugs Product Offered
13.13.3 Henan Lihua Pharmaceutical Hormonal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Henan Lihua Pharmaceutical Main Business Overview
13.13.5 Henan Lihua Pharmaceutical Latest Developments
13.14 Hubei Tiansheng Pharmaceutica
13.14.1 Hubei Tiansheng Pharmaceutica Company Information
13.14.2 Hubei Tiansheng Pharmaceutica Hormonal Drugs Product Offered
13.14.3 Hubei Tiansheng Pharmaceutica Hormonal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Hubei Tiansheng Pharmaceutica Main Business Overview
13.14.5 Hubei Tiansheng Pharmaceutica Latest Developments
13.15 Shandong Xinhua Pharmaceutical
13.15.1 Shandong Xinhua Pharmaceutical Company Information
13.15.2 Shandong Xinhua Pharmaceutical Hormonal Drugs Product Offered
13.15.3 Shandong Xinhua Pharmaceutical Hormonal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Shandong Xinhua Pharmaceutical Main Business Overview
13.15.5 Shandong Xinhua Pharmaceutical Latest Developments
13.16 Huazhong Pharmaceutical
13.16.1 Huazhong Pharmaceutical Company Information
13.16.2 Huazhong Pharmaceutical Hormonal Drugs Product Offered
13.16.3 Huazhong Pharmaceutical Hormonal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Huazhong Pharmaceutical Main Business Overview
13.16.5 Huazhong Pharmaceutical Latest Developments
13.17 China Resources Zizhu Pharmaceutical
13.17.1 China Resources Zizhu Pharmaceutical Company Information
13.17.2 China Resources Zizhu Pharmaceutical Hormonal Drugs Product Offered
13.17.3 China Resources Zizhu Pharmaceutical Hormonal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 China Resources Zizhu Pharmaceutical Main Business Overview
13.17.5 China Resources Zizhu Pharmaceutical Latest Developments
13.18 Shanghai CP GENERAL Pharmaceutical
13.18.1 Shanghai CP GENERAL Pharmaceutical Company Information
13.18.2 Shanghai CP GENERAL Pharmaceutical Hormonal Drugs Product Offered
13.18.3 Shanghai CP GENERAL Pharmaceutical Hormonal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Shanghai CP GENERAL Pharmaceutical Main Business Overview
13.18.5 Shanghai CP GENERAL Pharmaceutical Latest Developments
13.19 Jiangsu Lianhuan Pharmaceutical
13.19.1 Jiangsu Lianhuan Pharmaceutical Company Information
13.19.2 Jiangsu Lianhuan Pharmaceutical Hormonal Drugs Product Offered
13.19.3 Jiangsu Lianhuan Pharmaceutical Hormonal Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 Jiangsu Lianhuan Pharmaceutical Main Business Overview
13.19.5 Jiangsu Lianhuan Pharmaceutical Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Hormonal Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Hormonal Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Intravenous Injection
Table 4. Major Players of Take Orally
Table 5. Major Players of Topical
Table 6. Major Players of Others
Table 7. Global Hormonal Drugs Sales by Type (2017-2022) & (K Units)
Table 8. Global Hormonal Drugs Sales Market Share by Type (2017-2022)
Table 9. Global Hormonal Drugs Revenue by Type (2017-2022) & ($ million)
Table 10. Global Hormonal Drugs Revenue Market Share by Type (2017-2022)
Table 11. Global Hormonal Drugs Sale Price by Type (2017-2022) & (US$/Unit)
Table 12. Global Hormonal Drugs Sales by Sales Channels (2017-2022) & (K Units)
Table 13. Global Hormonal Drugs Sales Market Share by Sales Channels (2017-2022)
Table 14. Global Hormonal Drugs Revenue by Sales Channels (2017-2022)
Table 15. Global Hormonal Drugs Revenue Market Share by Sales Channels (2017-2022)
Table 16. Global Hormonal Drugs Sale Price by Sales Channels (2017-2022) & (US$/Unit)
Table 17. Global Hormonal Drugs Sales by Company (2020-2022) & (K Units)
Table 18. Global Hormonal Drugs Sales Market Share by Company (2020-2022)
Table 19. Global Hormonal Drugs Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Hormonal Drugs Revenue Market Share by Company (2020-2022)
Table 21. Global Hormonal Drugs Sale Price by Company (2020-2022) & (US$/Unit)
Table 22. Key Manufacturers Hormonal Drugs Producing Area Distribution and Sales Area
Table 23. Players Hormonal Drugs Products Offered
Table 24. Hormonal Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Hormonal Drugs Sales by Geographic Region (2017-2022) & (K Units)
Table 28. Global Hormonal Drugs Sales Market Share Geographic Region (2017-2022)
Table 29. Global Hormonal Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Hormonal Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Hormonal Drugs Sales by Country/Region (2017-2022) & (K Units)
Table 32. Global Hormonal Drugs Sales Market Share by Country/Region (2017-2022)
Table 33. Global Hormonal Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Hormonal Drugs Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Hormonal Drugs Sales by Country (2017-2022) & (K Units)
Table 36. Americas Hormonal Drugs Sales Market Share by Country (2017-2022)
Table 37. Americas Hormonal Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Hormonal Drugs Revenue Market Share by Country (2017-2022)
Table 39. Americas Hormonal Drugs Sales by Type (2017-2022) & (K Units)
Table 40. Americas Hormonal Drugs Sales Market Share by Type (2017-2022)
Table 41. Americas Hormonal Drugs Sales by Sales Channels (2017-2022) & (K Units)
Table 42. Americas Hormonal Drugs Sales Market Share by Sales Channels (2017-2022)
Table 43. APAC Hormonal Drugs Sales by Region (2017-2022) & (K Units)
Table 44. APAC Hormonal Drugs Sales Market Share by Region (2017-2022)
Table 45. APAC Hormonal Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Hormonal Drugs Revenue Market Share by Region (2017-2022)
Table 47. APAC Hormonal Drugs Sales by Type (2017-2022) & (K Units)
Table 48. APAC Hormonal Drugs Sales Market Share by Type (2017-2022)
Table 49. APAC Hormonal Drugs Sales by Sales Channels (2017-2022) & (K Units)
Table 50. APAC Hormonal Drugs Sales Market Share by Sales Channels (2017-2022)
Table 51. Europe Hormonal Drugs Sales by Country (2017-2022) & (K Units)
Table 52. Europe Hormonal Drugs Sales Market Share by Country (2017-2022)
Table 53. Europe Hormonal Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Hormonal Drugs Revenue Market Share by Country (2017-2022)
Table 55. Europe Hormonal Drugs Sales by Type (2017-2022) & (K Units)
Table 56. Europe Hormonal Drugs Sales Market Share by Type (2017-2022)
Table 57. Europe Hormonal Drugs Sales by Sales Channels (2017-2022) & (K Units)
Table 58. Europe Hormonal Drugs Sales Market Share by Sales Channels (2017-2022)
Table 59. Middle East & Africa Hormonal Drugs Sales by Country (2017-2022) & (K Units)
Table 60. Middle East & Africa Hormonal Drugs Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Hormonal Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Hormonal Drugs Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Hormonal Drugs Sales by Type (2017-2022) & (K Units)
Table 64. Middle East & Africa Hormonal Drugs Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Hormonal Drugs Sales by Sales Channels (2017-2022) & (K Units)
Table 66. Middle East & Africa Hormonal Drugs Sales Market Share by Sales Channels (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Hormonal Drugs
Table 68. Key Market Challenges & Risks of Hormonal Drugs
Table 69. Key Industry Trends of Hormonal Drugs
Table 70. Hormonal Drugs Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Hormonal Drugs Distributors List
Table 73. Hormonal Drugs Customer List
Table 74. Global Hormonal Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 75. Global Hormonal Drugs Sales Market Forecast by Region
Table 76. Global Hormonal Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Hormonal Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Hormonal Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 79. Americas Hormonal Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Hormonal Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 81. APAC Hormonal Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Hormonal Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Europe Hormonal Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Hormonal Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Middle East & Africa Hormonal Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Hormonal Drugs Sales Forecast by Type (2023-2028) & (K Units)
Table 87. Global Hormonal Drugs Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Hormonal Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Hormonal Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Hormonal Drugs Sales Forecast by Sales Channels (2023-2028) & (K Units)
Table 91. Global Hormonal Drugs Sales Market Share Forecast by Sales Channels (2023-2028)
Table 92. Global Hormonal Drugs Revenue Forecast by Sales Channels (2023-2028) & ($ Millions)
Table 93. Global Hormonal Drugs Revenue Market Share Forecast by Sales Channels (2023-2028)
Table 94. Merck Basic Information, Hormonal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Merck Hormonal Drugs Product Offered
Table 96. Merck Hormonal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 97. Merck Main Business
Table 98. Merck Latest Developments
Table 99. Roche Basic Information, Hormonal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. Roche Hormonal Drugs Product Offered
Table 101. Roche Hormonal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 102. Roche Main Business
Table 103. Roche Latest Developments
Table 104. Novartis Basic Information, Hormonal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. Novartis Hormonal Drugs Product Offered
Table 106. Novartis Hormonal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 107. Novartis Main Business
Table 108. Novartis Latest Developments
Table 109. Mitsubishi Tanabe Pharma Korea Basic Information, Hormonal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 110. Mitsubishi Tanabe Pharma Korea Hormonal Drugs Product Offered
Table 111. Mitsubishi Tanabe Pharma Korea Hormonal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 112. Mitsubishi Tanabe Pharma Korea Main Business
Table 113. Mitsubishi Tanabe Pharma Korea Latest Developments
Table 114. Anhui Renhe Pharmaceutical Basic Information, Hormonal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 115. Anhui Renhe Pharmaceutical Hormonal Drugs Product Offered
Table 116. Anhui Renhe Pharmaceutical Hormonal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 117. Anhui Renhe Pharmaceutical Main Business
Table 118. Anhui Renhe Pharmaceutical Latest Developments
Table 119. Shanghai ZhongHua Pharmaceutical Nantong Basic Information, Hormonal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 120. Shanghai ZhongHua Pharmaceutical Nantong Hormonal Drugs Product Offered
Table 121. Shanghai ZhongHua Pharmaceutical Nantong Hormonal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 122. Shanghai ZhongHua Pharmaceutical Nantong Main Business
Table 123. Shanghai ZhongHua Pharmaceutical Nantong Latest Developments
Table 124. He'nan Xuchang Huaren Pharmaceutical Basic Information, Hormonal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 125. He'nan Xuchang Huaren Pharmaceutical Hormonal Drugs Product Offered
Table 126. He'nan Xuchang Huaren Pharmaceutical Hormonal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 127. He'nan Xuchang Huaren Pharmaceutical Main Business
Table 128. He'nan Xuchang Huaren Pharmaceutical Latest Developments
Table 129. Wuhan Wujing Pharmaceutical Basic Information, Hormonal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 130. Wuhan Wujing Pharmaceutical Hormonal Drugs Product Offered
Table 131. Wuhan Wujing Pharmaceutical Hormonal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 132. Wuhan Wujing Pharmaceutical Main Business
Table 133. Wuhan Wujing Pharmaceutical Latest Developments
Table 134. Harbin Pharmaceutical Group Basic Information, Hormonal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 135. Harbin Pharmaceutical Group Hormonal Drugs Product Offered
Table 136. Harbin Pharmaceutical Group Hormonal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 137. Harbin Pharmaceutical Group Main Business
Table 138. Harbin Pharmaceutical Group Latest Developments
Table 139. Changzhou Siyao Pharmaceuticals Basic Information, Hormonal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 140. Changzhou Siyao Pharmaceuticals Hormonal Drugs Product Offered
Table 141. Changzhou Siyao Pharmaceuticals Hormonal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 142. Changzhou Siyao Pharmaceuticals Main Business
Table 143. Changzhou Siyao Pharmaceuticals Latest Developments
Table 144. Hunan Wzt Pharmaceutical Basic Information, Hormonal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 145. Hunan Wzt Pharmaceutical Hormonal Drugs Product Offered
Table 146. Hunan Wzt Pharmaceutical Hormonal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 147. Hunan Wzt Pharmaceutical Main Business
Table 148. Hunan Wzt Pharmaceutical Latest Developments
Table 149. Tianjin Tianyao Pharmaceutical Basic Information, Hormonal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 150. Tianjin Tianyao Pharmaceutical Hormonal Drugs Product Offered
Table 151. Tianjin Tianyao Pharmaceutical Hormonal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 152. Tianjin Tianyao Pharmaceutical Main Business
Table 153. Tianjin Tianyao Pharmaceutical Latest Developments
Table 154. Henan Lihua Pharmaceutical Basic Information, Hormonal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 155. Henan Lihua Pharmaceutical Hormonal Drugs Product Offered
Table 156. Henan Lihua Pharmaceutical Hormonal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 157. Henan Lihua Pharmaceutical Main Business
Table 158. Henan Lihua Pharmaceutical Latest Developments
Table 159. Hubei Tiansheng Pharmaceutica Basic Information, Hormonal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 160. Hubei Tiansheng Pharmaceutica Hormonal Drugs Product Offered
Table 161. Hubei Tiansheng Pharmaceutica Hormonal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 162. Hubei Tiansheng Pharmaceutica Main Business
Table 163. Hubei Tiansheng Pharmaceutica Latest Developments
Table 164. Shandong Xinhua Pharmaceutical Basic Information, Hormonal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 165. Shandong Xinhua Pharmaceutical Hormonal Drugs Product Offered
Table 166. Shandong Xinhua Pharmaceutical Hormonal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 167. Shandong Xinhua Pharmaceutical Main Business
Table 168. Shandong Xinhua Pharmaceutical Latest Developments
Table 169. Huazhong Pharmaceutical Basic Information, Hormonal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 170. Huazhong Pharmaceutical Hormonal Drugs Product Offered
Table 171. Huazhong Pharmaceutical Hormonal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 172. Huazhong Pharmaceutical Main Business
Table 173. Huazhong Pharmaceutical Latest Developments
Table 174. China Resources Zizhu Pharmaceutical Basic Information, Hormonal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 175. China Resources Zizhu Pharmaceutical Hormonal Drugs Product Offered
Table 176. China Resources Zizhu Pharmaceutical Hormonal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 177. China Resources Zizhu Pharmaceutical Main Business
Table 178. China Resources Zizhu Pharmaceutical Latest Developments
Table 179. Shanghai CP GENERAL Pharmaceutical Basic Information, Hormonal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 180. Shanghai CP GENERAL Pharmaceutical Hormonal Drugs Product Offered
Table 181. Shanghai CP GENERAL Pharmaceutical Hormonal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 182. Shanghai CP GENERAL Pharmaceutical Main Business
Table 183. Shanghai CP GENERAL Pharmaceutical Latest Developments
Table 184. Jiangsu Lianhuan Pharmaceutical Basic Information, Hormonal Drugs Manufacturing Base, Sales Area and Its Competitors
Table 185. Jiangsu Lianhuan Pharmaceutical Hormonal Drugs Product Offered
Table 186. Jiangsu Lianhuan Pharmaceutical Hormonal Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 187. Jiangsu Lianhuan Pharmaceutical Main Business
Table 188. Jiangsu Lianhuan Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Hormonal Drugs
Figure 2. Hormonal Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hormonal Drugs Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Hormonal Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Hormonal Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Intravenous Injection
Figure 10. Product Picture of Take Orally
Figure 11. Product Picture of Topical
Figure 12. Product Picture of Others
Figure 13. Global Hormonal Drugs Sales Market Share by Type in 2021
Figure 14. Global Hormonal Drugs Revenue Market Share by Type (2017-2022)
Figure 15. Hormonal Drugs Consumed in Hospital
Figure 16. Global Hormonal Drugs Market: Hospital (2017-2022) & (K Units)
Figure 17. Hormonal Drugs Consumed in Pharmacy
Figure 18. Global Hormonal Drugs Market: Pharmacy (2017-2022) & (K Units)
Figure 19. Hormonal Drugs Consumed in Clinic
Figure 20. Global Hormonal Drugs Market: Clinic (2017-2022) & (K Units)
Figure 21. Global Hormonal Drugs Sales Market Share by Sales Channels (2017-2022)
Figure 22. Global Hormonal Drugs Revenue Market Share by Sales Channels in 2021
Figure 23. Hormonal Drugs Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Hormonal Drugs Revenue Market Share by Company in 2021
Figure 25. Global Hormonal Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Hormonal Drugs Revenue Market Share by Geographic Region in 2021
Figure 27. Global Hormonal Drugs Sales Market Share by Region (2017-2022)
Figure 28. Global Hormonal Drugs Revenue Market Share by Country/Region in 2021
Figure 29. Americas Hormonal Drugs Sales 2017-2022 (K Units)
Figure 30. Americas Hormonal Drugs Revenue 2017-2022 ($ Millions)
Figure 31. APAC Hormonal Drugs Sales 2017-2022 (K Units)
Figure 32. APAC Hormonal Drugs Revenue 2017-2022 ($ Millions)
Figure 33. Europe Hormonal Drugs Sales 2017-2022 (K Units)
Figure 34. Europe Hormonal Drugs Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Hormonal Drugs Sales 2017-2022 (K Units)
Figure 36. Middle East & Africa Hormonal Drugs Revenue 2017-2022 ($ Millions)
Figure 37. Americas Hormonal Drugs Sales Market Share by Country in 2021
Figure 38. Americas Hormonal Drugs Revenue Market Share by Country in 2021
Figure 39. United States Hormonal Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Hormonal Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Hormonal Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Hormonal Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Hormonal Drugs Sales Market Share by Region in 2021
Figure 44. APAC Hormonal Drugs Revenue Market Share by Regions in 2021
Figure 45. China Hormonal Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Hormonal Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Hormonal Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Hormonal Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Hormonal Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Hormonal Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Hormonal Drugs Sales Market Share by Country in 2021
Figure 52. Europe Hormonal Drugs Revenue Market Share by Country in 2021
Figure 53. Germany Hormonal Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Hormonal Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Hormonal Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Hormonal Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Hormonal Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Hormonal Drugs Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Hormonal Drugs Revenue Market Share by Country in 2021
Figure 60. Egypt Hormonal Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Hormonal Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Hormonal Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Hormonal Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Hormonal Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Hormonal Drugs in 2021
Figure 66. Manufacturing Process Analysis of Hormonal Drugs
Figure 67. Industry Chain Structure of Hormonal Drugs
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets